
Joint radionuclide therapy-immunotherapy approach effective in prostate cancer model
A combination of radionuclide therapy and immunotherapy has proven successful in slowing the progression of…
A combination of radionuclide therapy and immunotherapy has proven successful in slowing the progression of…
Targeted radionuclide therapy has been found to create a favourable tumour microenvironment in prostate cancer…
Radionuclide therapy has proven successful in delaying the growth of disseminated tumour cells (DTCs) in…
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate…